Literature DB >> 26053779

Three Serious Drug Interactions that Every Dentist Should Know About.

Elliot V Hersh1, Paul A Moore2.   

Abstract

Patients with complex medical and drug histories are becoming more commonplace in dental practice. This article reviews three serious adverse drug interactions that are well supported by the literature and can impact dental practice. Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit the renal excretion of lithium and lead to lithium toxicity. Metronidazole and fluconazole inhibit the metabolism of warfarin by blocking cytochrome P-450 2C9 (CYP-2C9), the major metabolic pathway of warfarin, with the end result being dramatic increases in patients' international normalized ratios (INRs) and potentially fatal bleeding. Propranolol and other nonselective beta-adrenergic blocking agents can inhibit the vasodilatory effect of epinephrine in dental local anesthetic solutions, leading to hypertensive reactions and a concomitant reflex bradycardia. It is important for clinicians to recognize and avoid these serious drug interactions. By doing so, they will provide the safest and best treatment for their patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26053779

Source DB:  PubMed          Journal:  Compend Contin Educ Dent        ISSN: 1548-8578


  3 in total

1.  Cardiac Arrest Upon Induction of General Anesthesia.

Authors:  Regina A E Dowdy; Shadee T Mansour; James H Cottle; Hannah R Mabe; Harry B Weprin; Leigh E Yarborough; Gregory M Ness; Todd M Jacobs; Bryant W Cornelius
Journal:  Anesth Prog       Date:  2021-03-01

2.  Nonsteroidal Anti-Inflammatory Drugs and Opioids in Postsurgical Dental Pain.

Authors:  E V Hersh; P A Moore; T Grosser; R C Polomano; J T Farrar; M Saraghi; S A Juska; C H Mitchell; K N Theken
Journal:  J Dent Res       Date:  2020-04-14       Impact factor: 6.116

3.  Medication discrepancies in the dental record and impact of pharmacist-led intervention.

Authors:  Hailey J Choi; Autumn L Stewart; Chunhao Tu
Journal:  Int Dent J       Date:  2017-05-20       Impact factor: 2.607

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.